Iovance Biotherapeutics, Inc. (IOVA)
2.87
+0.02
(+0.70%)
USD |
NASDAQ |
Feb 20, 16:00
2.87
0.00 (0.00%)
After-Hours: 20:00
Iovance Biotherapeutics Market Cap : 1.139B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| KalVista Pharmaceuticals, Inc. | 800.15M |
| Lantheus Holdings, Inc. | 4.898B |
| Plus Therapeutics, Inc. | 37.79M |
| BioStem Technologies, Inc. | 101.50M |
| Protokinetix, Inc. | 3.069M |
Market Cap Related Metrics
| PS Ratio | 3.80 |
| Price to Book Value | 1.622 |
| Price | 2.87 |
| Earnings Yield | -41.88% |